Letter | Published:

De novo deletions of SNRPN exon 1 in early human and mouse embryos result in a paternal to maternal imprint switch

  • An Erratum to this article was published on 01 June 2000

Abstract

Prader-Willi syndrome (PWS) is a neurogenetic disease characterized by infantile hypotonia, gonadal hypoplasia, obsessive behaviour and neonatal feeding difficulties followed by hyperphagia, leading to profound obesity1. PWS is due to a lack of paternal genetic information at 15q11–q13 (ref. 2). Five imprinted, paternally expressed genes map to the PWS region, MKRN3 (ref. 3), NDN (ref. 4), NDNL1 (ref. 5), SNRPN (refs 68) and IPW (ref. 9), as well as two poorly characterized framents designated PAR-1 and PAR-5 (ref. 10). Imprinting of this region involves a bipartite ‘imprinting centre’ (IC), which overlaps SNRPN (refs 10,11). Deletion of the SNRPN promoter/exon 1 region (the PWS IC element) appears to impair the establishment of the paternal imprint in the male germ line and leads to PWS. Here we report a PWS family in which the father is mosaic for an IC deletion on his paternal chromosome. The deletion chromosome has acquired a maternal methylation imprint in his somatic cells. We have made identical findings in chimaeric mice generated from two independent embryonic stem (ES) cell lines harbouring a similar deletion. Our studies demonstrate that the PWS IC element is not only required for the establishment of the paternal imprint, but also for its postzygotic maintenance.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Holm, V.A. et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91, 398–402 ( 1993).

  2. 2

    Nicholls, R.D., Saitoh, S. & Horsthemke, B. Imprinting in Prader-Willi and Angelman syndromes. Trends Genet. 14, 194–200 (1998).

  3. 3

    Jong, M.T. et al. A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. Hum. Mol. Genet. 8, 783– 793 (1999).

  4. 4

    MacDonald, H.R. & Wevrick, R. The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse. Hum. Mol. Genet. 6, 1873–1878 (1997).

  5. 5

    Boccaccio, I. et al. The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region. Hum. Mol. Genet . 8, 2497–2505 ( 1999).

  6. 6

    Ozcelik, T. et al. Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region. Nature Genet. 2, 265–269 (1992).

  7. 7

    Glenn, C.C., Porter, K.A., Jong, M.T., Nicholls, R.D. & Driscoll, D.J. Functional imprinting and epigenetic modification of the human SNRPN gene. Hum. Mol. Genet. 2, 2001–2005 (1993).

  8. 8

    Reed, M.L. & Leff, S.E. Maternal imprinting of human SNRPN, a gene deleted in Prader-Willi syndrome. Nature Genet . 6, 163–167 ( 1994).

  9. 9

    Wevrick, R., Kerns, J.A. & Francke, U. Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum. Mol. Genet. 3, 1877–1882 (1994).

  10. 10

    Sutcliffe, J.S. et al. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nature Genet. 8, 52–58 ( 1994).

  11. 11

    Buiting, K. et al. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nature Genet. 9, 395–400 (1995).

  12. 12

    Zechnigk, M., Lich, C., Buiting, K., Doerfler, W. & Horsthemke, B. A single tube PCR test for the diagnosis of Angelman and Prader-Willi syndrome based on allelic methylation differences at the SNRPN locus. Eur. J. Hum. Genet. 5, 94–98 (1997).

  13. 13

    Färber, C., Dittrich, B., Buiting, K. & Horsthemke, B. The chromosome 15 imprinting centre (IC) region has undergone multiple duplication events and contains an upstream exon of SNRPN that is deleted in all Angelman syndrome patients with an IC microdeletion. Hum. Mol. Genet. 8, 337–343 (1999).

  14. 14

    Yang, T. et al. A mouse model for Prader-Willi syndrome imprinting-centre mutations . Nature Genet. 19, 25– 31 (1998).

  15. 15

    Bultman, S.J., Michaud, E.J. & Woychik, R.P. Molecular characterization of the mouse agouti locus . Cell 71, 1195–1204 (1992).

  16. 16

    Blaydes, S.M., Elmore, M., Yang, T. & Brannan, C.I. Analysis of murine Snrpn and human SNRPN gene imprinting in transgenic mice . Mamm. Genome 10, 549– 555 (1999).

  17. 17

    Buiting, K. et al. Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis. Am. J. Hum. Genet. 67, 170–180 (1998).

  18. 18

    Laird, P.W. et al. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19, 4293–4294 (1991).

  19. 19

    Schumacher, A., Buiting, K., Zeschnigk, M., Doerfler, W. & Horsthemke, B. Methylation analysis of the PWS/AS region does not support an enhancer-competition model. Nature Genet . 19, 324–325 ( 1998).

  20. 20

    Dittrich, B., Buiting, K., Gross, S. & Horsthemke, B. An insertion/deletion polymorphism at the D15S63 locus in the critical Prader-Willi syndrome region in 15q11–q13. Hum. Genet. 94, 583– 584 (1994).

  21. 21

    Dittrich, B. et al. Molecular diagnosis of the Prader-Willi and Angelman syndromes by detection of parent-of-origin specific DNA methylation in 15q11–13 . Hum. Genet. 90, 313–315 (1992).

  22. 22

    Buiting, K. et al. Detection of aberrant DNA methylation in unique Prader-Willi syndrome patients and its diagnostic implications. Hum. Mol. Genet . 3, 893–895 ( 1994).

  23. 23

    Jay, P. et al. The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nature Genet. 17, 357–361 ( 1997).

  24. 24

    Swiatek, P.J. & Gridley, T. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev. 7, 2071 –2084 (1993).

  25. 25

    Li, E., Bestor, T.H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915–926 (1992).

  26. 26

    Robertson, E.J. Embryo-derived stem cells. in Teratocarcinomas and Embryonic Stem Cells. A Practical Approach (ed. Robertson, E.J.) 71– 112 (IRL, Oxford, 1987).

  27. 27

    Hogan, B., Beddington, R., Constantini, F. & Lacy, E. Manipulating the Mouse Embryo. A Laboratory Manual (Cold Spring Harbor Laboratory Press, New York, 1994).

  28. 28

    Wevrick, R. & Francke, U. An imprinted mouse transcript homologous to the human Imprinted in Prader-Willi syndrome (IPW) gene. Hum. Mol. Genet. 6, 325–332 (1997).

  29. 29

    Jong, M.T. et al. Imprinting of a RING zinc-finger encoding gene in the mouse chromosome region homologous to the Prader-Willi syndrome genetic region. Hum. Mol. Genet. 8, 795–803 (1999).

Download references

Acknowledgements

We thank M.A. Handel for consulting on the interpretation of testis histology; C. Lich for technical assistance; E. Michaud for the agouti probe; F. Muscatelli for the NDN probe; D. Lohmann for the Rbe7 probe; T. Gridley for the CJ.7 ES line; the Jaenisch lab for the J4 ES line; and C. Färber, M. Zeschnigk and G. Gillessen-Kaesbach for helpful discussion. This work was supported, in part, by a grant from the National Institutes of Health (GM55272 to C.I.B.) and a grant from the Deutsche Forschungsgemeinschaft (Ho 949/12-2 to B.H.). S.M.B. was supported by an NIH training grant (T32 CA09126).

Author information

Correspondence to Bernhard Horsthemke.

Rights and permissions

Reprints and Permissions

About this article

Further reading

Figure 1: Molecular analysis of the PWS family WW.
Figure 2: Microsatellite analysis.
Figure 3: Methylation analysis of the PWS family at four loci outside the deletion.
Figure 4: Targeted disruptions of the Snrpn locus and identification of the parental origin of the targeted allele.
Figure 5: Expression analysis of three paternally expressed imprinted genes in IC deletion mice.
Figure 6: Analysis of the level of methylation at three differentially methylated restriction sites in six different control and chimaeric tissues.